.jpg?width=2560&height=1440&name=2003-009%20(2).jpg)
Featured Post
Red Dot: Best of the Best — The PharmaPrinter Aurum Takes Design's Highest Honor
Red Dot: Best of the Best — The PharmaPrinter Aurum Takes Design's Highest Honor
Some weeks you remember forever. Days after signing our $14M Series A, our team walked onto the Red Dot stage in Essen, Germany, to accept the Best of the Best award for the PharmaPrinter Aurum — the jury's highest distinction, reserved for the most groundbreaking product designs of the year.
Let's be honest about what that stage looks like. The Red Dot Award: Product Design is where the giants of industrial design collect their trophies — global consumer electronics brands, automotive icons, design houses with decades of heritage. And there we were, a Finnish health technology company that makes pharmaceutical compounding equipment, standing with the big boys on stage. We belonged there, and the trophy agrees.
Interview with Vanity Thomas, from The Woodlands Compounding Pharmacy
Discover why Vanity Thomas from The Woodlands Compounding Pharmacy prefers the CurifyLabs Compounding System Solution in our latest interview.
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Live From Training the Helios Erfurt Pharmacy Team!
3D printed medicines Helios Erfurt Pharmacy automated compounding technology non-sterile
Interview with Dr. Florian Immekus, Pharmacy Director, Mühlenkreiskliniken, Germany
Interview with Dr. Florian Immekus, Pharmacy Director, Mühlenkreiskliniken, Minden, Germany
Jana Lass, Tartu Hospital Pharmacy
Insights from Jana Lass at Tartu Hospital on integrating CurifyLabs' 3D-printing technology for personalized medicine, addressing stakeholder feedback and future possibilities in hospital settings.
Dr. Marija Tubic Grozdanis & Prof. Dr. Alexandra Russo, University Medical Center Mainz
Exploring the role of personalized medicine in pediatric cancer treatment with insights from experts at the University Medical Center Mainz. Discover the future of tailored therapies for children.
Samuli Ojala, Vaasan Hietalahden Apteekki
Discover the importance of personalized medicine through compounding and how it benefits niche patient groups like pets, children, and the elderly.
Interview with Erik Haeffler, CEO, APL
Interview with Erik Haeffler on APL's role in developing personalized medicines for patients with unique needs using innovative CSS-technology.